RIS ID
55050
Abstract
Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of refractory schizophrenia in the region. Utilising a pharmacoepidemiological approach; the results indicated that only 8.4% of the individuals estimated to be suffering from refractory schizophrenia in the region were prescribed clozapine between 2005 and 2010, with only 4.1% continuing clozapine to the conclusion of the study. In conclusion it is evident that clozapine is widely under-prescribed in this area of Australia.
Publication Details
Vella, S. C. Pai, N. Brahmavar. (2012). Prevalence Prescription: Prescribing practices of clozapine in Australia between 2005 2010. Online Journal of Health and Allied Sciences, 11 (1), 1-2.